Free CME from PeerView


Oncology CME

Lecia V. Sequist, MD, MPH
Credits: 0.75 CME / MOC / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Practical Approach to Implementing Lung Cancer Screening for High-Risk Individuals
April 17, 2024
Olalekan Oluwole, MBBS, MPH
Credits: 1.0 CME / NCPD
PVI, PeerView Institute for Medical Education
Democratizing the CAR-T Experience: The Principles and Practice of Outpatient Cellular Therapy
April 16, 2024
Meghan C. Thompson, MD
Credits: 0.75 CME / MOC / NCPD / CPE / AAPA / IPCE
PVI, PeerView Institute for Medical Education
From Resistance to Resilience in R/R CLL: Sequencing Strategies for Achieving Effective Continuous Care
April 05, 2024
Carlos G. Romo, MD/Aimee Sato, MD
Credits: 1.0 CME / MOC
PeerView Institute for Medical Education
Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & Multimodal Care for NF1 pNF and Other Tumors
April 03, 2024
Lipika Goyal, MD, MPhil/Riad Salem, MD, MBA
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
The Convergence of Interventional Radiologists and Oncologists in HCC: Shared Decision-Making and Care Coordination at the Center of Personalized Care Across the Disease Continuum
March 27, 2024
Roy F. Chemaly, MD, MPH, FIDSA, FACP/Genovefa Papanicolaou, MD, FIDSA, Fellow ASCT
Credits: 1.0 CME / NCPD
PVI, PeerView Institute for Medical Education
Cracking Down on Post-Transplant CMV: Guidance on Sequential Treatment With Newer Antiviral Agents
March 26, 2024
Sergio A. Giralt, MD, FACP/Brittany Knick Ragon, MD
Credits: 1.0 CME / NCPD
The Medical College of Wisconsin
Reinforcing the “Bridge” to HCT in AML: Clinical Conversations on Augmenting Efficacy With Innovative Options as Pre-Transplant and Maintenance Strategies
March 26, 2024
Laura S. Dominici, MD, FACS
Credits: 1.0 CME / MOC / CC
PVI, PeerView Institute for Medical Education
Unraveling the Complex Choices in Early Breast Cancer: A Roadmap to Informed Multidisciplinary Decisions About Assessment and Treatment
March 22, 2024
Jennifer Wargo, MD, MMSc
Credits: 1.50 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
New Chapters in the Immunotherapy Story for Melanoma: Collaborative Care and Next Steps With Adjuvant and Neoadjuvant Therapy
March 22, 2024
Krina Patel, MD, MSc/Hans Lee, MD
Credits: 1.0 CME / NCPD
PVI, PeerView Institute for Medical Education
Accelerating Remission in Multiple Myeloma: Updates on CAR-T, BCMA Antibodies, and Achieving Deep Responses & Enduring Efficacy
March 22, 2024
Prof. Mohamad Mohty, MD, PhD/Christine N. Duncan, MD
Credits: 1.0 CME / NCPD
PVI, PeerView Institute for Medical Education
Canceling the Cascade of VOD/SOS: Team-Based Prophylaxis, Diagnosis, and Customized Management
March 21, 2024
Prof. Dr. med. Stephan Stilgenbauer
Credits: 1.0 CME / MOC / CPD
PVI, PeerView Institute for Medical Education
Finite Therapy, Infinite Possibilities in CLL: Exploring the Rapid Emergence of Newer Time-Limited BTKi Combinations
March 19, 2024
Kathleen N. Moore, MD, MS
Credits: 1.25 CME / MOC / NCPD / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies
March 18, 2024
Bradley J. Monk, MD, FACS, FACOG
Credits: 1.0 CME / MOC / NCPD / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Implementation Strategies, and Patient Care
March 17, 2024
Hussein Tawbi, MD, PhD
Credits: 0.5 CME / MOC / NCPD / CPE / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Taking the Front Seat in Metastatic Melanoma Care: Guidance on Using PD-1/LAG-3 Platforms as Modern First-Line Options
March 11, 2024
Prof. Laurence Albiges, MD, PhD
Credits: 0.5 CME / MOC / NCPD / CPE / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Exploring New Routes in Immuno-Oncology: Understanding the Role of Subcutaneous Immune Checkpoint Inhibitors & Preparing for Innovative Delivery Approaches in the Clinic
March 08, 2024
Reshma L. Mahtani, DO
Credits: 1.0 CME / MOC / NCPD / IPCE
PVI, PeerView Institute for Medical Education
A Clinical Compass for Selecting and Sequencing HER2-Targeting Therapies in HER2-Positive Metastatic Breast Cancer: An Update on the Latest Evidence, Guidelines, and Expert Insights
March 05, 2024
Alok A. Khorana, MD, FACP, FASCO
Credits: 0.75 CME / MOC / AAPA / IPCE
PVI, PeerView Institute for Medical Education
REVIVE Initiative: Reinforcing Evidence-Based Principles Against Cancer-Associated Venous Thromboembolism
March 01, 2024
Benjamin Levy, MD
Credits: 1.0 CME / MOC / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung Cancer
February 24, 2024
Taofeek K. Owonikoko, MD, PhD
Credits: 1.0 CME / MOC / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Accelerating the Transition of Emerging Strategies to the Clinic
February 24, 2024
Credits: 1.0 CME / MOC / AAPA / IPCE
Making Precision Decisions in the Treatment of NSCLC With Common and Uncommon EGFR Mutations: How to Navigate the Expanding Options and Increasing Complexity
February 21, 2024
Kurt A. Schalper, MD, PhD/Vamsidhar Velcheti, MD
Credits: 0.75 CME / MOC
PVI, PeerView Institute for Medical Education
PATHway to Decoding the Impact of Cancer Immunotherapy: Latest Advances in Biomarker Testing and Pathologic Response Assessment
February 15, 2024
Brendon M. Stiles, MD
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Building Multidisciplinary Partnerships to Facilitate Genomic Testing and Master the Integration of EGFR-Targeted Therapy in Resectable Stage I-III NSCLC
January 28, 2024
Jessica Donington, MD/Jonathan D. Spicer, MD, PhD, FRCSC
Credits: 1.0 CME / MOC / CC / AAPA
PVI, PeerView Institute for Medical Education
A Practical Guide for Making Multidisciplinary Decisions About Neoadjuvant and/or Adjuvant Immunotherapy in Resectable NSCLC
January 28, 2024
Matthew D. Galsky, MD
Credits: 1.50 CME / MOC / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Making an Impact in Bladder Cancer Care: Integrating the Latest Evidence and Modern Therapeutic Advances Across the Disease Continuum
January 27, 2024
Lipika Goyal, MD, MPhil/Riad Salem, MD, MBA
Credits: 0.75 CME / MOC / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Synergizing for Success in HCC: Immunotherapy Advances and the Role of the Interventional Radiologist-Oncologist Collaboration Across the Disease Continuum
January 27, 2024
Robert Dreicer, MD, MS, MACP, FASCO
Credits: 1.5 CME / MOC / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies
January 26, 2024
Sumanta Kumar Pal, MD, FASCO
Credits: 1.5 CME / MOC / NCPD / AAPA / IPCE
PVI, PeerView Institute for Medical Education
Advancing Personalized Care in RCC: Navigating Rapid Therapeutic Expansion and Sequencing Strategies
January 26, 2024

Pages